bpc-157 not approved by fda statement for human use The Food and Drug Administration's committee on An FDA Committee Just Voted

BPC 157 may modulate inflammatory responses in tissue models, which is relevant for laboratory studies on injury recovery and inflammation regulation

This peptide has an amino acid sequence that mimics the lipolytic region of human growth hormone (the region of this hormone thought to be responsible for burning fat) and it has been promoted variously as a weight loss supplement, as an aid to muscle and cartilage repair, and a treatment for osteoarthritis by its manufacturers

Some practitioners prefer it because of this, arguing that patients with certain metabolic variants may convert cyanocobalamin less efficiently

Youll need to check with your insurance provider

All products are for laboratory research and development use only, and are not intended for human use